New Key Statistics Module, Z-Score and F-Score
NAS:AKYA Key Ratios
| Market Cap $ M | 143.22 |
| Enterprise Value $ M | 140.35 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.21 |
| Price/Sales | 1.40 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 93.00 |
| EPS (TTM) $ | -1.45 |
| Beneish M-Score | -2.77 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.57 |
| EV-to-EBITDA | -3.08 |
| PEG | -- |
| Shares Outstanding M | 49.38 |
| Net Margin (%) | -72.68 |
| Operating Margin % | -59.70 |
| Pre-tax Margin (%) | -72.60 |
| Quick Ratio | 2.38 |
| Current Ratio | 3.07 |
| ROA % (ttm) | -39.74 |
| ROE % (ttm) | -129.54 |
| ROIC % (ttm) | -73.43 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.73 |
AKYA Number of Guru Trades
AKYA Volume of Guru Trades
Gurus Latest Trades with NAS:AKYA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AKYA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Akoya Biosciences Inc Insider Transactions
No Available Data
News about NAS:AKYA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers